Related Experiment Video

Updated: Aug 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

[Management of psychological disorders in patients with chronic hepatitis C]

B Badin De Montjoye1, I Ferrand, P Sogni

  • 1Service de Psychiatrie, Hôpital Cochin, 75014 Paris, France.

L'Encephale
|August 17, 2006
PubMed

Insights

Chronic hepatitis C (HCV) infection affects many in France. Effective treatment requires managing psychiatric side effects and strong patient-provider collaboration for better outcomes.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Psychiatry

Context:

  • Chronic hepatitis C is a significant public health issue in France, impacting 400,000-500,000 individuals.
  • Antiviral therapies for HCV can present psychiatric side effects that require careful consideration.

Purpose:

  • To review the clinical aspects and treatment guidelines for chronic hepatitis C.
  • To highlight the psychiatric side effects associated with antiviral treatments.
  • To emphasize the importance of patient-provider interaction and multidisciplinary care.

Summary:

  • This review synthesizes current knowledge on chronic hepatitis C, focusing on clinical manifestations and antiviral treatment outcomes.
  • It specifically addresses the psychiatric adverse effects of these treatments, underscoring the need for integrated management.
  • Optimal patient care involves dynamic collaboration between hepatologists and psychiatrists to enhance patient satisfaction and treatment efficacy.

Impact:

  • Implementing multidisciplinary approaches is crucial for improving the management and outcomes of patients with chronic hepatitis C.
  • Enhanced patient-provider communication and psychiatric support can lead to better treatment adherence and satisfaction.
  • This review advocates for a coordinated care model involving specialists to address the complex needs of HCV patients.
Abstract

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...